questionText: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the severity modifier criteria on access to drugs for cancer patients.
answerText: The National Institute for Health and Care Excellence (NICE) has been monitoring the impact of the severity modifier since it was implemented in 2022. Data up to March 2025 shows that the proportion of positive cancer recommendations is higher (85%) than ...
heading: Cancer: Drugs